“Anastomosis Devices Market Report is set to have rapid growth due the rising surgical procedures along with growing incidence of cardiovascular and gastrointestinal diseases at global, regional and national level, influencing the industry trends in each of the sub-segments from 2019 to 2029”, says Visiongain Report
04 September 2019
Visiongain has launched a new pharma report Anastomosis Devices Market Report : Forecast By Product (Disposable, Reusable), By Application (Cardiovascular Surgery, Gastrointestinal Surgery), By Region, Competitive Landscape, and Segment Forecasts.
The global Anastomosis Devices market is poised for rapid growth between 2019 and 2029. The increase in the number of cardiovascular surgical procedures performed and an increase in the prevalence of chronic diseases, such as gastrointestinal and cardiac disorders, are the main factors driving the global market for anastomotic devices worldwide.
According to the European Commission, about 181,000 bypass anastomoses for heart revascularization procedures were performed in the 25 EU Member States in 2016. Among them, Germany conducted about 51,000 cardiac bypass operations in 2016. This will probably fuel the demand of anastomotic devices in the near future.
Furthermore, rapid technological progress is expected to be a favorable reimbursement scenario for cardiac procedures, including coronary artery bypass grafting (CABG), open heart valve replacement and angioplasty, in regions developed for encourage the adoption of anastomotic devices during the forecast period. However, the complications associated with anastomosis, such as anastomotic leaks, are expected to hamper the global market for anastomotic devices.
Leading companies featured in the report include Medtronic; LivaNova PLC; MAQUET Holding B.V. & Co. KG.; Dextera Surgical Inc.; Vitalitec Internaional Inc.; Synovis Micro Companies Alliance, Inc.; and Ethicon US, LLC.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.
09 April 2021
The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.
06 April 2021
Factors such as increasing data volumes for analysis, quick turnaround time for the discovery and development new drug, computing power, AI also helps in targeted manufacturing and others drive the market growth.
01 April 2021
Rising prevalence of chronic respiratory diseases including asthma, COPD, and allergic rhinitis; rising geriatric population, escalating investment in drug R&D by biopharmaceutical & pharmaceutical companies; growing respiratory health care awareness; and new product launches worldwide are some of the major factors that boosting the growth of global inhalation & nasal spray generic drugs market.